HOME > BUSINESS
BUSINESS
- Takeda Releases App for IBD Patients; Sharing Info with Doctors
July 11, 2019
- Life Science Institute Begins Muse Cell Trial for Spinal Injury; President Confident of Profitability
July 10, 2019
- Sumitomo Dainippon, NCGM Launch AMR Project in Vietnam
July 10, 2019
- Riona Shows Non-Inferiority vs. Ferromia in Iron Deficiency Anemia: JT/Torii
July 10, 2019
- Long-Term Efficacy, Safety Confirmed for Hemlibra: Roche/Chugai
July 10, 2019
- Large-Scale Study Unveils 14.7% of Ovarian Cancer Patients Carry BRCA Mutations in Japan: AstraZeneca
July 10, 2019
- Daiichi Sankyo Espha Set to Push Drug Adherence for Cancer AGs, Boost Added Value for Generics
July 9, 2019
- Eisai, Dundee Univ. Ink Oncology Drug Discovery Deal
July 9, 2019
- Vortioxetine Hits Japan PIII Target for MDD: Takeda/Lundbeck
July 9, 2019
- Maviret, Lyrica Sell Big; Avastin Presumed No. 1 in FY2018 Drug Ranking: Tally
July 8, 2019
- Keytruda Retains Top Slot in Drug Sales Ranking in June: Encise Snapshot
July 8, 2019
- Japan Ethical Drug Sales Down 3.8% in May Due to Holidays: Crecon
July 8, 2019
- CureApp’s Smoking Cessation App under Review as Medical Device; Reimbursement Price Will Be Key: President
July 8, 2019
- Genomic Profiling Tests Need More of Private Insurer Involvement: Prof.
July 5, 2019
- Allogeneic Cell Therapies Well Suited to Pharma's Biz Model, Education of Data Scientists Important: Astellas Chairman
July 4, 2019
- Claw-Back Clause Thwarted, but Majority of Takeda Shareholders Voted in Favor
July 4, 2019
- Avastin Most Prescribed Drug at Acute Hospitals in 2018
July 3, 2019
- Sumitomo Dainippon’s Napabucasin Flops in Pancreatic Cancer Trial
July 3, 2019
- Takeda Completes Divestment of Dry Eye Drug Xiidra to Novartis
July 3, 2019
- Fujifilm Launches New US Company to Develop Allogeneic iPS Cell-Derived Cancer Immunotherapies
July 3, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
